Skip to main content
. 2023 Dec 17;11(12):3336. doi: 10.3390/biomedicines11123336

Table 2.

Comparison of neuropsychiatric data between different HD stages: #: higher scores = more impairment.

HD Stage 1
n = 3319
HD Stage 2
n = 3580
HD Stage 3
n = 2296
HD Stage 4
n = 809
HD Stage 5
n = 310
F p Part. Eta2
Clinical rater (PBA-s)
Depression;
M (SD) #
4.63 (5.81)
(n = 3315)
5.66 (6.65)
(n = 3571)
5.51 (6.90)
(n = 2278)
5.05 (6.30)
(n = 775)
4.53 (5.77)
(n = 205)
13.241 <0.001 0.005
Irritability;
M (SD) #
2.62 (3.99) 3.40 (4.82) 3.83 (5.63) 4.53 (6.42) 5.04 (6.65) 42.44 <0.001 0.016
Psychosis;
M (SD) #
0.14 (1.10) 0.31 (1.61) 0.50 (2.22) 0.86 (3.21) 0.61 (2.03) 31.74 <0.001 0.012
Apathy;
M (SD) #
1.76 (3.03) 3.24 (3.93) 5.12 (4.96) 6.71 (5.86) 8.11 (6.47) 411.00 <0.001 0.139
Executive function;
M (SD) #
1.97 (3.76) 3.33 (5.04) 5.01 (6.25) 6.69 (7.41) 5.84 (7.04) 199.82 <0.001 0.073
Self-report (HADS-IS)
Anxiety; M (SD) # 5.76 (4.08)
(n = 2055)
6.20 (4.31)
(n = 2116)
6.09 (4.31)
(n = 1093)
6.12 (4.34)
(n = 269)
5.84 (4.54)
(n = 46)
3.00 0.018 0.002
Depression;
M (SD) #
4.95 (3.78) 6.38 (4.05) 7.30 (4.39) 8.32 (4.92) 9.22 (4.75) 93.28 <0.001 0.063
Irritability;
M (SD) #
5.77 (4.39) 6.24 (4.76) 5.95 (4.73) 5.62 (4.62) 5.42 (4.01) 3.31 <0.001 0.002
Outward irritability;
M (SD) #
3.47 (2.64) 3.73 (2.88) 3.65 (2.94) 3.58 (3.08) 3.43 (2.60) 2.45 0.044 0.002
Inward irritability;
M (SD) #
2.31 (2.35) 2.51 (2.54) 2.31 (2.58) 2.06 (2.39) 2.07 (2.24) 3.30 0.011 0.002